Characterisation of a recombinant Fv fragment of anti-MUC1 antibody HMFG1.

[1]  M. Price,et al.  Polymorphic epithelial mucins (PEM): molecular characteristics and association with breast cancer , 1993 .

[2]  J. Saunders,et al.  Construction of a reshaped HMFG1 antibody and comparison of its fine specificity with that of the parent mouse antibody. , 1993, Immunology.

[3]  D. Jackson,et al.  Structural and computational investigations of the conformation of antigenic peptide fragments of human polymorphic epithelial mucin. , 1992, The Biochemical journal.

[4]  N. Peat,et al.  Structure and biology of a carcinoma-associated mucin, MUC1. , 1991, The American review of respiratory disease.

[5]  M. Price,et al.  Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. , 1991, Journal of immunological methods.

[6]  J. Anglister,et al.  Nuclear magnetic resonance for studying peptide-antibody complexes by transferred nuclear Overhauser effect difference spectroscopy. , 1991, Methods in enzymology.

[7]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[8]  R. W. Baldwin,et al.  Immunological and structural features of the protein core of human polymorphic epithelial mucin. , 1990, Molecular immunology.

[9]  S. Tendler.  Elements of secondary structure in a human epithelial mucin core peptide fragment. , 1990, The Biochemical journal.

[10]  J. Bártková,et al.  A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomas , 1989, International journal of cancer.

[11]  V. Zurawski,et al.  Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  W. Bodmer,et al.  Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in culture , 1981, International journal of cancer.

[13]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.